You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Hers
since
auto-detected in 44 stories
20 days ago
Hers has always been a gilded existence, but Alice, 49, never made the mistake of thinking she was invulnerable to the cruel luck that can strike anyone.
34 days ago
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more ○
found
These are some of the stocks seeing the largest midday moves.
35 days ago
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more ○
These are some of the stocks posting the largest midday moves.
36 days ago
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs ⊖
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
54 days ago
Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more ○
These are the stocks posting the largest moves in the premarket.
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion ⊕
found
The deal would give Hims & Hers a foothold in Australia and Japan while deepening its presence in the United Kingdom, Germany, and Canada.
63 days ago
Wegovy maker sues rival over 'knock-off' weight-loss drugs ⊖
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".
The race for cheaper GLP-1 drugs is hitting legal limits ⊖
found
The push to make weight loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and ris…
64 days ago
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill ⊕
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
65 days ago
Hims & Hers pulls copycat weight-loss pill after threats of legal action ⊖
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.